L
Ligand Pharmaceuticals Incorporated (LGND)
NGM – Real Time Price. Currency in USD
222.00
+1.52 (0.69%)
At close: May 12, 2026, 4:00 PM EDT
218.00
-4.00 (-1.80%)
After-hours: May 12, 2026, 7:24 PM EDT
Find any stock by ticker or company name

NGM – Real Time Price. Currency in USD
222.00
+1.52 (0.69%)
At close: May 12, 2026, 4:00 PM EDT
218.00
-4.00 (-1.80%)
After-hours: May 12, 2026, 7:24 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 21.28 | 6.05 | 10 | |
| Quick ratio | 20.95 | 5.63 | 10 | |
| Debt to Equity | 0.45 | 0.30 | 7.0 | |
| Debt to Assets | 0.29 | 1.04 | 7.0 | |
| Interest coverage | N/A | -16.91 | 10 | |
| Weighted average score | 8.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 196M | 131M | 167M | 268M | 274M |
| Gross Profit | 119M | 88M | 121M | 221M | 238M |
| Operating Income | 13M | 10M | 23M | 47M | 101M |
| Net Income | -33M | 52M | -4M | 124M | 154M |
| EBITDA | 56M | 47M | 60M | 81M | 110M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 34.35 | 25.27 | 10 |
| Next quarter | -32.56 | -19.05 | 1.0 |
| Current year | 5.84 | 11.16 | 6.0 |
| Next year | 26.85 | 22.49 | 10 |
| Weighted average score | 6.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -13.3 | -129.79 | -19.3 | 249.15 | 3.3 |
| Y/Y | 14.09 | 68.56 | 22.56 | 66.08 | 9.5 |
| 3y average | 18.2 | 1111.75 | 61.83 | -0.19 | 7.5 |
| 5y average | 13.09 | 1038.21 | 37.1 | 22.07 | 9.5 |
| Weighted average score | 7.5 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Cash reserves $0.0 barely cover the upcoming debt maturities $452.0M
Total current assets $865.4M exceed Total current liabilities $40.7M, highlighting excellent liquidity
Debt-to-equity ratio (0.5) is well below the industry average (0.3), showcasing prudent financial management
The company has no interest-bearing debt, showcasing excellent financial strength